Focal therapy of neuroblastoma using silk films to deliver kinase and chemotherapeutic agents in vivo

Acta Biomaterialia

Volumn 20, Issue , 2015, Pages 32-38

  Seib, F Philipp ^a   Coburn, Jeannine ^b   Konrad, Ilona ^b   Klebanov, Nikolai ^b   Jones, Gregory T ^c   Blackwood, Brian ^d   Charest, Alain ^e   Kaplan, David L ^b   Chiu, Bill ^f  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b Tufts University   (United States)

^c TUFTS UNIVERSITY   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chemotherapy; Controlled release; Neuroblastoma; Silk

Indexed keywords

CONTROLLED DRUG DELIVERY; SILK; TARGETED DRUG DELIVERY;

'CURRENT; CHEMOTHERAPEUTIC AGENTS; CONTROLLED RELEASE; DOXORUBICIN; FOCAL THERAPIES; IN-VITRO; IN-VIVO; NEUROBLASTOMAS; SILK; SILK FILMS;

CHEMOTHERAPY;

CRIZOTINIB; DOXORUBICIN; NANOCOATING; ANTINEOPLASTIC AGENT; PROTEIN KINASE INHIBITOR; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; SILK;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BOMBYX MORI; CANCER PATIENT; CANCER THERAPY; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG RELEASE; FILM; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; SILK FILM; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; CHEMISTRY; FEMALE; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MICE, NUDE; NEUROBLASTOMA; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIDINES; SILK;

EID: 84929516279     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.04.003     Document Type: Article

References (35)

1. J.M. Maris Recent advances in neuroblastoma N Engl J Med 362 2010 2202 2211
2. J. Hara Development of treatment strategies for advanced neuroblastoma Int J Clin Oncol 17 2012 196 203
3. S.W. Warmann, G. Seitz, J.F. Schaefer, H.G. Scheel-Walter, I. Leuschner, and J. Fuchs Vascular encasement as element of risk stratification in abdominal neuroblastoma Surg Oncol 20 2011 231 235
4. E.L. Carpenter, and Y.P. Mosse Targeting ALK in neuroblastoma-preclinical and clinical advancements Nat Rev Clin Oncol 9 2012 391 399
5. Y. Chen, J. Takita, Y.L. Choi, M. Kato, M. Ohira, and M. Sanada Oncogenic mutations of ALK kinase in neuroblastoma Nature 455 2008 971 974
6. R.E. George, T. Sanda, M. Hanna, S. Frohling, W. Luther 2nd, and J. Zhang Activating mutations in ALK provide a therapeutic target in neuroblastoma Nature 455 2008 975 978
7. M.P. La Quaglia, B.H. Kushner, W. Su, G. Heller, K. Kramer, and S. Abramson The impact of gross total resection on local control and survival in high-risk neuroblastoma J Pediatr Surg 39 2004 412 417 discussion -7
8. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
9. R. Duncan, and R. Gaspar Nanomedicine(s) under the microscope Mol Pharm 8 2011 2101 2141
10. D. de Melo-Diogo, V.M. Gaspar, E.C. Costa, A.F. Moreira, D. Oppolzer, and E. Gallardo Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment Eur J Pharm Biopharm 88 2014 718 729
11. J.G. Marques, V.M. Gaspar, D. Markl, E.C. Costa, E. Gallardo, and I.J. Correia Co-delivery of Sildenafil (Viagra((R))) and Crizotinib for synergistic and improved anti-tumoral therapy Pharm Res 31 2014 2516 2528
12. F. Pastorino, C. Brignole, M. Loi, D. Di Paolo, A. Di Fiore, and P. Perri Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma Front Oncol 3 2013 190
13. U. Veronesi, N. Cascinelli, L. Mariani, M. Greco, R. Saccozzi, and A. Luini Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 2002 1227 1232
14. H. Brem, S. Piantadosi, P.C. Burger, M. Walker, R. Selker, and N.A. Vick Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The polymer-brain tumor treatment group Lancet 345 1995 1008 1012
15. M. Westphal, Z. Ram, V. Riddle, D. Hilt, and E. Bortey Executive Committee of the Gliadel Study G. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial Acta Neurochir (Wien) 148 2006 269 275 discussion 75
16. F.G. Omenetto, and D.L. Kaplan New opportunities for an ancient material Science 329 2010 528 531
17. F. Vollrath, and D. Porter Silks as ancient models for modern polymers Polymer 50 2009 5623 5632
18. F.P. Seib, and D.L. Kaplan Silk for drug delivery applications: opportunities and challenges Isr J Chem 53 2013 756 766
19. F.P. Seib, E.M. Pritchard, and D.L. Kaplan Self-assembling doxorubicin silk hydrogels for the focal treatment of primary breast cancer Adv Funct Mater 23 2013 58 65
20. F.P. Seib, G.T. Jones, J. Rnjak-Kovacina, Y.N. Lin, and D.L. Kaplan pH-dependent anticancer drug release from silk nanoparticles Adv Healthcare Mater 2 2013 1606 1611
21. D.H. Kim, J. Viventi, J.J. Amsden, J. Xiao, L. Vigeland, and Y.S. Kim Dissolvable films of silk fibroin for ultrathin conformal bio-integrated electronics Nat Mater 9 2010 511 517
22. R.H. Kim, D.H. Kim, J. Xiao, B.H. Kim, S.I. Park, and B. Panilaitis Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics Nat Mater 9 2010 929 937
23. B. Cirillo, M. Morra, and G. Catapano Adhesion and function of rat liver cells adherent to silk fibroin/collagen blend films Int J Artif Organs 27 2004 60 68
24. C.J. Kearney, and D.J. Mooney Macroscale delivery systems for molecular and cellular payloads Nat Mater 12 2013 1004 1017
25. D.N. Rockwood, R.C. Preda, T. Yucel, X. Wang, M.L. Lovett, and D.L. Kaplan Materials fabrication from Bombyx mori silk fibroin Nat Protoc 6 2011 1612 1631
26. F.P. Seib, and D.L. Kaplan Doxorubicin-loaded silk films: drug-silk interactions and in vivo performance in human orthotopic breast cancer Biomaterials 33 2012 8442 8450
27. X. Ma, C. Cao, and H. Zhu The biocompatibility of silk fibroin films containing sulfonated silk fibroin J Biomed Mater Res B Appl Biomater 78 2006 89 96
28. L. Meinel, S. Hofmann, V. Karageorgiou, C. Kirker-Head, J. McCool, and G. Gronowicz The inflammatory responses to silk films in vitro and in vivo Biomaterials 26 2005 147 155
29. B. Panilaitis, G.H. Altman, J. Chen, H.J. Jin, V. Karageorgiou, and D.L. Kaplan Macrophage responses to silk Biomaterials 24 2003 3079 3085
30. T. Yucel, M.L. Lovett, and D.L. Kaplan Silk-based biomaterials for sustained drug delivery J Control Release 2014
31. B. Chiu, J. Coburn, M. Pilichowska, C. Holcroft, F.P. Seib, and A. Charest Surgery combined with controlled-release doxorubicin silk films as a treatment strategy in an orthotopic neuroblastoma mouse model Br J Cancer 2014
32. J.H. Doroshow, G.Y. Locker, I. Ifrim, and C.E. Myers Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine J Clin Invest 68 1981 1053 1064
33. K.K. Matthay, R.E. George, and A.L. Yu Promising therapeutic targets in neuroblastoma Clin Cancer Res 18 2012 2740 2753
34. A. Lammel, M. Schwab, M. Hofer, G. Winter, and T. Scheibel Recombinant spider silk particles as drug delivery vehicles Biomaterials 32 2011 2233 2240
35. D.J. Hines, and D.L. Kaplan Mechanisms of controlled release from silk fibroin films Biomacromolecules 12 2011 804 812